Picture of Vitrolife AB logo

VITR — Vitrolife AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Vitrolife Group Makes An Impairment Charge Of Sek 4.3 Billion Relating To Igenomix

Jan 23 (Reuters) - Vitrolife AB  VITR.ST :
    * VITROLIFE GROUP MAKES AN IMPAIRMENT CHARGE OF SEK 4.3
BILLION
RELATING TO IGENOMIX AND PROVIDES PRELIMINARY FINANCIALS FOR THE
FOURTH QUARTER 2023
    * VITROLIFE - PRELIMINARY FIGURES FOR Q4, WITH SALES OF SEK
904
MILLION, CORRESPONDING TO 6% GROWTH IN SEK, GROSS MARGIN OF
56.9% AND EBITDA MARGIN OF 32.5%.
    * VITROLIFE - IMPAIRMENT REPRESENTS 31% OF TOTAL AMOUNT OF
ACCOUNTED GOODWILL AND OTHER INTANGIBLE ASSETS ATTRIBUTED TO
ACQUISITION OF IGENOMIX
    * VITROLIFE - IMPAIRMENT PARTLY DUE TO INFLATED GOODWILL, BY
APPRECIATION OF SHARE PRICE BETWEEN SIGNING AND ISSUANCE OF NEW
SHARES DURING TRANSACTION

Source text for Eikon:  ID:nWkr2jpNyl 
Further company coverage:  VITR.ST 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Vitrolife AB

See all news